ARCHIVES

FDA Advisory Committee To Consider NDAs On Novantrone, HD MTX

This article is from The Cancer Letter archive.

Vol. 13 No. 46 | November 27, 1987

Download PDF Visit The Full Archive

Related Articles

Lawyer Says Salick didn’t Anticipate Ouster By Zeneza

May 2, 1997

DCBD Board Okays Recompetition Of Human Tissue Network

June 30, 1989

New Drug for Lymphoma Enters Phase II Trial

May 28, 2004

Aromasin Approved By FDA For ER+ Early Breast Cancer

October 28, 2005

Stronger Anti-Smoking Efforts Needed For Women, SG Says.

March 30, 2001

NCAB Member Pollin Organizes Minority Outreach Effort

January 4, 1991